Trifluridine Tipiracil,bevacizumab
pfizer,roche
['solstice']
join #asco23's poster discussion session on #gastrointestinalcancer at 1:15pm cdt and find out about mark saunder's work on the phase 3 solstice study and the overall survival results: #crukfunded 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK